Patents by Inventor Gene Cutler

Gene Cutler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticancer agents
    Patent number: 11730736
    Abstract: Disclosed herein are therapeutic methods of administering compounds that modulate the C—C chemokine receptor type 4 (CCR4) for the treatment of Epstein Bar virus (EBV) positive cancers and malignancies.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: August 22, 2023
    Assignee: RAPT Therapeutics, Inc.
    Inventors: Gene Cutler, William Yew-Wai Ho, Paul David Kassner, Silpa Suthram, Brian Russell Wong
  • Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
    Patent number: 11084829
    Abstract: Disclosed herein, inter alia, compounds and methods of use thereof for the modulation of USP7 activity.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: August 10, 2021
    Assignee: RAPT THERAPEUTICS, INC.
    Inventors: Berenger Biannic, Xinping Han, Dennis X. Hu, Paul Robert Leger, Jack Maung, Akinori Okano, Jacob Bradley Schwarz, David Juergen Wustrow, Kyle Young, Gene Cutler, Yamini Ohol-Gupta
  • UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF
    Publication number: 20200095260
    Abstract: Disclosed herein, inter alia, compounds and methods of use thereof for the modulation of USP7 activity.
    Type: Application
    Filed: September 20, 2019
    Publication date: March 26, 2020
    Inventors: Berenger Biannic, Xinping Han, Dennis X. Hu, Paul Robert Leger, Jack Maung, Akinori Okano, Jacob Bradley Schwarz, David Juergen Wustrow, Kyle Young, Gene Cutler, Yamini Ohol-Gupta
  • ANTICANCER AGENTS
    Publication number: 20190134031
    Abstract: Disclosed herein are therapeutic methods of administering compounds that modulate the C—C chemokine receptor type 4 (CCR4) for the treatment of Epstein Bar virus (EBV) positive cancers and malignancies.
    Type: Application
    Filed: November 5, 2018
    Publication date: May 9, 2019
    Inventors: Gene Cutler, William Yew-Wai Ho, Paul David Kassner, Silpa Suthram, Brian Russell Wong
  • Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof
    Patent number: 8735548
    Abstract: The present invention provides fusion proteins expressed by cancer cells, antibodies and other antigen-binding agents that specifically bind to the fusion proteins, and compositions and methods for using the antibodies and other antigen-binding agents to detect, characterize, and treat cancer.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: May 27, 2014
    Assignee: Amgen Inc.
    Inventors: Kim Coign Quon, Gene Cutler, Jennifer Joy Kordich
  • FUSION PROTEINS IN CANCER
    Publication number: 20130095111
    Abstract: The present invention provides fusion proteins expressed by cancer cells, antibodies and other antigen-binding agents that specifically bind to the fusion proteins, and compositions and methods for using the antibodies and other antigen-binding agents to detect, characterize, and treat cancer.
    Type: Application
    Filed: June 28, 2011
    Publication date: April 18, 2013
    Applicant: AMGEN INC.
    Inventors: Kim Coign Quon, Gene Cutler, Jennifer Joy Kordich
  • Novel receptors
    Publication number: 20090226436
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: April 9, 2009
    Publication date: September 10, 2009
    Inventors: Hui Tian, Kang Dai, Jin-Long Chen, Jiagang Zhao, Gene Cutler
  • Novel receptors
    Publication number: 20080113449
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: January 9, 2008
    Publication date: May 15, 2008
    Inventors: Hui Tian, Kang Dai, Jin-Long Chen, Jiagang Zhao, Gene Cutler
  • Novel Receptors
    Publication number: 20070141644
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: February 28, 2007
    Publication date: June 21, 2007
    Inventors: Hui Tian, Kang Dai, Jin-Long Chen, Jiagang Zhao, Gene Cutler
  • G protein-coupled receptors
    Publication number: 20060223109
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: June 14, 2006
    Publication date: October 5, 2006
    Applicant: Amgen, Inc.
    Inventors: Hui Tian, Jiagang Zhao, Jin-Long Chen, Gene Cutler
  • G-protein coupled receptors
    Patent number: 7084259
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: August 1, 2006
    Assignee: Amgen Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • Novel G-protein coupled receptors
    Publication number: 20060166309
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Application
    Filed: December 20, 2001
    Publication date: July 27, 2006
    Applicant: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • Novel receptors
    Publication number: 20050182245
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: March 21, 2005
    Publication date: August 18, 2005
    Applicant: Tularik Inc.
    Inventors: Hui Tian, Jiagang Zhao, Jin-Long Chen, Gene Cutler
  • Novel receptors
    Publication number: 20050170397
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Application
    Filed: January 18, 2005
    Publication date: August 4, 2005
    Applicant: Tularik Inc.
    Inventors: Hui Tian, Jiagang Zhao, Jin-Long Chen, Gene Cutler, Songzhu An, Kang Dai, Jamila Gupte
  • Novel G-protein coupled receptors
    Publication number: 20040029232
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Application
    Filed: August 4, 2003
    Publication date: February 12, 2004
    Applicant: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • G-protein coupled receptors amplified in breast cancer
    Patent number: 6638733
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: October 28, 2003
    Assignee: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • G-protein coupled receptor BCA-GPCR-3
    Patent number: 6635741
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: October 21, 2003
    Assignee: Tularik Inc.
    Inventors: Scott Powers, Jianxin Yang, Gene Cutler
  • Novel receptors
    Publication number: 20030082585
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: July 1, 2002
    Publication date: May 1, 2003
    Applicant: Tularik
    Inventors: Hui Tian, Kang Dai, Jin-Long Chen, Jiagang Zhao, Gene Cutler
  • Novel receptors
    Publication number: 20030083245
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: June 25, 2001
    Publication date: May 1, 2003
    Applicant: Tularik Inc.
    Inventors: Daniel Chi-Hong Lin, Jiagang Zhao, Jin-Long Chen, Gene Cutler
  • Novel receptors
    Publication number: 20030045685
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of novel receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of the receptors.
    Type: Application
    Filed: March 8, 2002
    Publication date: March 6, 2003
    Applicant: Tularik Inc.
    Inventors: Hui Tian, Jiagang Zhao, Jin-Long Chen, Gene Cutler